Progressive Molecules Private Limited
About Progressive Molecules Private Limited
Data last updated:
Progressive Molecules Private Limited is a private limited company based in Cachar, Assam, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 May 2023.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U46497AS2023PTC024554.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sandeep Kumar Mollick and Priya Banik.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Ramkrishna Sarani Sonai Road Silchar. Cachar, Assam, India – 788007.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.09 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹40.02 Lakh (net margin -153.4%) and EBITDA of -₹34.4 Lakh (EBITDA margin -131.9%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Ramkrishna Sarani Sonai Road Silchar. Cachar, Assam, India – 788007
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Progressive Molecules Private Limited
The main business activity of Progressive Molecules is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Progressive Molecules Private Limited FY 2025 filings available
Progressive Molecules Private Limited reported revenue of ₹26.09 Lakh (up 2819% YoY) for FY 2025.
Financial Statement Summary of Progressive Molecules Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹34.4 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹40.02 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Progressive Molecules Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -131.9% | •••• |
| Net Profit Margin | -153.4% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Progressive Molecules are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Progressive Molecules Private Limited
Progressive Molecules Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Keywest Korp Private Limited | ₹26.33 Lakh (FY 2019) | •••• | •••• | 36.0% | •••• | Noida, Uttar Pradesh, India |
| Anghu Pharma Private Limited | ₹26.28 Lakh (FY 2021) | •••• | •••• | -59.0% | •••• | Dindigul, Tamil Nadu, India |
| Smilen Pharmaceuticals Private Limited | ₹26.24 Lakh (FY 2025) | •••• | •••• | 164.0% | •••• | Dombivli, Maharashtra, India |
| Sheetal Enterprises Ltd. | ₹26.14 Lakh (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Sritanshi Health Care India Private Limited | ₹26.14 Lakh (FY 2025) | •••• | •••• | 55.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Progressive Molecules Private Limited this company | ₹26.09 Lakh (FY 2025) | •••• | •••• | 2819.0% | •••• | Cachar, Assam, India |
| Majesty Medicare Private Limited | ₹26.05 Lakh (FY 2019) | •••• | •••• | 46.0% | •••• | Sant Ravi Das Nagar, Uttar Pradesh, India |
| Glaze Healthcare Private Limited | ₹26.03 Lakh (FY 2018) | •••• | •••• | -25.0% | •••• | Agra, Uttar Pradesh, India |
| Roussel Laboratories Private Limited | ₹26.01 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Ahmedabad, Gujarat, India |
| Bavium Pharmaceuticals Private Limited | ₹25.97 Lakh (FY 2024) | •••• | •••• | 7.0% | •••• | Aurangabad, Maharashtra, India |
| Linchpin Biosciences Private Limited | ₹25.86 Lakh (FY 2025) | •••• | •••• | -1.0% | •••• | Navi Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Progressive Molecules by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Progressive Molecules Private Limited
Progressive Molecules has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Kumar Mollick | Director | 02 May 2023 | 3 Years 5 Months | Current |
| Priya Banik | Director | 02 May 2023 | 3 Years 5 Months | Current |
| Anupriya Deb | Director | 02 May 2023 | 3 Years 5 Months | Current |
Charges & Borrowings of Progressive Molecules Private Limited
Progressive Molecules Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Progressive Molecules Private Limited
Employment history and EPFO contributions of people linked to Progressive Molecules.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Progressive Molecules Private Limited
Progressive Molecules Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Anupriya Deb was appointed as Director on 02 May 2023.
Credit Ratings, Litigation & Regulatory Alerts for Progressive Molecules Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Progressive Molecules Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Progressive Molecules Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Progressive Molecules Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Progressive Molecules Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Progressive Molecules Private Limited
Progressive Molecules is an active private limited company based in Cachar, Assam, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 May 2023 (3+ years old) and is registered under CIN U46497AS2023PTC024554.
Progressive Molecules reported revenue of ₹26.09 Lakh for FY 2025 (up 2819% YoY).
Progressive Molecules has 3 current directors:
- Sandeep Kumar Mollick - Director
- Priya Banik - Director
- Anupriya Deb - Director
Progressive Molecules reported a net loss of ₹40.02 Lakh (net margin -153.4%) and EBITDA of -₹34.4 Lakh (EBITDA margin -131.9%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Progressive Molecules is U46497AS2023PTC024554. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Progressive Molecules was incorporated on 02 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Guwahati.
The peers of Progressive Molecules by revenue are Keywest Korp Private Limited, Anghu Pharma Private Limited, Smilen Pharmaceuticals Private Limited, Sheetal Enterprises Ltd, Sritanshi Health Care India Private Limited and 5 more, all in the Pharma industry (Formulations).
Anupriya Deb was appointed as Director on 02 May 2023. Priya Banik was appointed as Director on 02 May 2023. Sandeep Kumar Mollick was appointed as Director on 02 May 2023.
The registered office of Progressive Molecules is at CO Ramkrishna Sarani Sonai Road Silchar. Cachar, Assam, India – 788007.
Progressive Molecules has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Progressive Molecules operates in the pharma industry, in the drug formulation and development segment.